Abstract: A battery sensor with addressing mode and detection mode capability comprising a processor, an input interface, an output interface, an addressing channel and a detection channel; the processor connected to at least one battery parameter detection circuit; the addressing channel used a series connection manner to connect with a series connection input interface of the input interface, the processor and a series connection output interface of the output interface; a first communication interface of the input interface and a second communication interface of the output interface can be parallel connected to the processor by the detection channel; wherein the battery sensor can execute a battery addressing mode by the addressing channel, and the battery sensor can execute a battery parameter detection mode by the detection channel.

Abstract: The present invention encompasses PRLR binding proteins. Specifically, the invention relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Preferred antibodies have high affinity for hPRLR and neutralize hPRLR activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hPRLR and for inhibiting hPRLR activity, e.g., in a human subject suffering from a disorder in which hPRLR activity is detrimental. Also included in the invention are anti-PRLR antibody drug conjugates (ADCs).

Abstract: Apparatuses, methods and systems for hybrid powertrain control are disclosed. Certain example embodiments control an internal combustion engine and a motor/generator of a hybrid electric powertrain. Example controls may determine a total output demanded of a powertrain based at least in part upon an operator input, a battery output target based upon a battery state of charge and independent of the operator input, and an engine output target based upon the total output demanded and the battery output target. Such example controls may further determine a constrained engine output target, a modified battery output target based upon the total output demanded and the constrained engine output target, and a constrained battery output target based upon the modified battery output target and a battery constraint. Further embodiments, forms, objects, features, advantages, aspects, and benefits shall become apparent from the following description and figures.

Abstract: A tire includes a tire body, a sealing film fastened to two side edge portions of the tire body and defining a gas chamber with the tire body, and a nozzle including an inserting member and an exterior screw member. The inserting member has an inner stopping portion disposed on an inner surface of the sealing film, a screw rod extended from the inner stopping portion and through the sealing film, and a gas-charging channel passing through the inner stopping portion and the screw rod and communicating with the gas chamber. The exterior screw member is screwed onto the screw rod and directly or indirectly urged against an outer surface of the sealing film.

Abstract: According to various embodiments, a reagent fluid dispensing device may be provided. The reagent fluid dispensing device may include a chamber for receiving a reagent fluid, the chamber having a first opening and a second opening; a first fluid conduit connected to the first opening of the chamber; a reservoir connected to the first fluid conduit, the reservoir having a first opening, wherein the first opening of the reservoir is connected to the first fluid conduit to form a passive valve, wherein the reservoir is dimensionalized for storing a predetermined volume of the reagent fluid; and a pneumatic conduit connected to the second opening of the chamber, wherein selective application of pneumatic pressure to the chamber through the pneumatic conduit transfers the reagent fluid from the reservoir to the chamber through the first fluid conduit. According to various embodiments, a microfluidic device including the reagent fluid dispensing device, and a method of dispensing a reagent fluid may be provided.

Abstract: A foldable tire includes a tire main body provided at two edges thereof with two tire beads respectively. A plurality of rings are disposed in each of the tire beads. Each of the rings has a reinforcing core, which includes a plurality of flexible steel filaments helically entwined with each other and has a diameter ranging from 0.2 millimeters to 0.5 millimeters, and a cladding layer clothing the reinforcing core, so that the reinforcing cores located in each of the tire beads are separated from each other.

Abstract: Disclosed is a voltage regulating circuit, comprising an input end, an output end, a protecting switch, a first switch, a second switch, a third switch, a first coil and a second coil. The third switch comprises a first terminal and a second terminal. The second terminal of the third switch is connected to a third terminal of the first switch. One end of the first coil is connected to a second terminal of the first switch, and the other end of the first coil is connected to a third terminal of the first switch. One end of the second coil is connected to a first terminal of the third switch, and the other end of the second coil is connected to a fourth terminal of the protecting switch. Different connections between switches and the transformer provide various voltage adjustments to reduce power loss and to increase power transformation efficiency.

Abstract: An improved opening for a metal faucet has an outlet neck having an opening with an outer threaded section at an outer edge and a curved stopping ring at the opening, the stopping ring having a rounded surface at an inner edge. The improved opening for a metal faucet which does not have any sharp edge and provide smooth water flows.

Abstract: The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind and neutralize RGM A protein. Specifically, these antibodies have the ability to inhibit the binding of RGM A to its receptor and/or coreceptors. These antibodies or portions thereof of the invention are useful for detecting RGM A and for inhibiting RGM A activity, for example in a human suffering from a disorder including but nor limited to multiple sclerosis, mammalian brain trauma, spinal cord injury, stroke, neurodegenerative diseases, and schizophrenia.

Abstract: The instant disclosure relates to a chassis structure for industrial uninterruptible power supply system including: a chassis having a frame and a front side panel, left side panel, right side panel, rear side panel and top panel installed on the frame; the chassis has a plurality of spacer on the bottom thereof for lifting the chassis from the ground for a distance to forming a gas-intake space; a plurality of protective plates disposed around the gas-intake space, each protective plate has a plurality of gas-intake hole; a bottom plate structure disposed between the bottom of the chassis and the gas-intake space and has at least a gas-intake gap; at least a venting hole disposed on the top panel of the chassis, each venting hole has at least an exhaust fan for outputting a gas from the chassis.

Abstract: The present disclosure illustrates a dual-mode regulator circuit comprising: a first output terminal; a second output terminal; a switching regulator circuit coupled to the first output terminal and comprising a first transistor coupled between the first output terminal and ground; a linear regulator circuit coupled to the second output terminal and comprising a second transistor coupled between the second output terminal and a power source; a detection circuit configured to turn on the first transistor in order to connect the first output terminal to ground, turn on the second transistor in order to connect the second output terminal to the power source, and then generate a detection signal indicating whether an inductor is connected between the first and second output terminals; and a logic circuit configured to activate the switching regulator circuit or the linear regulator circuit according to the detection signal.

Abstract: Proteins that bind IL-17 and/or IL-17F are described along with their use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions.

Abstract: Engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease are provided.

Abstract: A battery management system having capability for addressing and time-division communication, the battery management system comprises a controller and a plurality of sensors, the sensors can communicatively connect to the controller; wherein each sensor has a communication port, the controller can transmit a plurality of addressing commands to address each of the sensors, each of the sensors can control the communication period of each communication port in accordance with its received addressing command, therefore the sensors and the controller can execute the time-division communication.

Abstract: A power optimization device and method thereof for energy harvesting apparatus are disclosed. The power optimization device includes a charge pump, a voltage comparator, an output switch, a counter and a frequency control module. By detecting the voltage outputted from the power optimization device under various operating frequencies to obtain a calculation result and increase or decrease an operating frequency of the charge pump according to the calculation result, so as to dynamically adjust the operating frequency to optimize the power outputted from the power optimization device according to the voltage outputted from the energy harvesting apparatus to an electricity storage unit and energy loss caused by the change of the operating frequency.

Abstract: Provided are protein, nucleic acid, and cellular libraries of single chain multivalent binding proteins (e.g., scDVD and scDVDFab molecules) and methods of using these of these libraries for the screening of single chain multivalent binding proteins using cell surface display technology (e.g., yeast display).

Abstract: The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind and neutralize RGM A protein. Specifically, these antibodies have the ability to inhibit the binding of RGM A to its receptor and/or coreceptors. These antibodies or portions thereof of the invention are useful for detecting RGM A and for inhibiting RGM A activity, for example in a human suffering from a disorder including but nor limited to multiple sclerosis, mammalian brain trauma, spinal cord injury, stroke, neurodegenerative diseases, and schizophrenia.

Abstract: A PDU (power distribution unit) having capability for remaining power management, the PDU has a plurality of first outlets, the PDU can electrically connect with a UPS (Uninterruptible Power Supply), the PDU and the UPS can be communicatively connected to a manager; wherein the PDU can receive a remaining power parameter which is transmitted from the UPS, the manager can use the user interface to display the remaining power parameter, and the manager can use the user interface to set up at least one outlet action, the PDU can control at least one the first outlet to execute the outlet action according to the remaining power parameter.

Abstract: The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.